Posts Tagged


Photo of a warning graphic painted on a gray wall.
CBD News

Stock prices for Curaleaf, a major CBD brand, fell this week after the FDA sent the company a warning letter for “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.”

Read More